PSA BDP Secures GDP Certification for Global Sites
Logistics providers now face increased pressure to obtain independent quality verification for pharmaceutical shipping.
Updated on Oct. 29, 2026 in Transportation
Live Poll
Do you trust logistics companies more when their quality standards are independently verified?
Logistics firm PSA BDP secured Good Distribution Practice certification for facilities across four countries. The status serves as independent verification of the company's quality management systems for temperature-controlled shipping.
Why it matters
This certification allows the company to meet the compliance requirements of pharmaceutical clients who must verify the integrity of their logistics partners. It provides a standardized assurance for cold-chain operations across key global markets.
PSA BDP obtained Good Distribution Practice certification for sites in four countries, with plans to expand the program to include four additional nations by 2027. The certification validates quality management systems required for transporting sensitive pharmaceutical products.
The players
PSA BDP
A global logistics and transportation provider specializing in supply chain solutions and temperature-controlled freight.
The details
The certification process involves a multi-site audit that confirms the company can maintain rigorous standards for temperature-controlled goods. By standardizing these quality management systems, PSA BDP positions itself as a verified partner for life science companies operating in complex regulatory environments. The move reflects an industry-wide effort to reduce supply chain risks associated with temperature-sensitive pharmaceutical distribution.
Timeline
October 29, 2026: The company announced the achievement of the GDP certification.
2027: The firm plans to expand the certification program to include facilities in Belgium, China, India, and Ireland.
Market Landscape
This development follows established Good Distribution Practice (GDP) guidelines, which serve as the primary international benchmark for pharmaceutical supply chain integrity. By standardizing these practices across global sites, the company aligns with a broader industry trend of prioritizing rigorous quality control to win contracts in the highly regulated life sciences sector.
Operators managing temperature-sensitive shipments should view these certifications as a baseline requirement when auditing potential logistics partners. Businesses currently evaluating their pharmaceutical supply chains should verify if their current providers hold comparable third-party quality certifications to ensure regulatory compliance.
The takeaway
Third-party certifications like GDP function as a critical competitive signal in the pharmaceutical logistics market. Operators should monitor if their current logistics vendors are tracking toward similar 2027 certification expansions to maintain parity in quality assurance standards.
What happens next
PSA BDP is scheduled to expand its certification program to Belgium, China, India, and Ireland throughout 2027.
Further reading
For broader trends in logistics compliance and quality standards, visit Transportation.
Source note: This article includes information reported by American Journal of Transportation | AJOT | 1-800-599-6358.
Live Poll
Do you trust logistics companies more when their quality standards are independently verified?
